The StressTek™ Platform
Our StressTek™ platform allows us to perform drug discovery in a unique and effective way:
Our insight relies on endogenous stress pathways from anti-apoptotic cells. These cells release signals to the immune system to avoid cell destruction. To identify targets and pathways, we gather those signals emitted, compare to our gene tolerance network, and identify the key drivers of tolerance.
We identified SER-101 as a strong candidate for Lupus through this platform. We are continuing to explore the use of this discovery engine to generate more therapeutics with interested partners.